Skip to content
10-Q

Quarterly Report

Serina Therapeutics, Inc. SER

0001708599-25-000089

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 10.25M sh
Shares Diluted Q2 2025 · Jun 30, 2025 10M sh
Shares Diluted Q2 2025 · Jun 30, 2025 9.88M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 10.16M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 5.65M sh
Capex Q2 2025 · Jun 30, 2025 $46K
Capex Q2 2025 · Jun 30, 2024 $14K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$8.07M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$9.59M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $6.04M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.67M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.8M
Stockholders Equity Q2 2025 · Dec 31, 2024 $641K
Current Liabilities Q2 2025 · Jun 30, 2025 $3.56M
Current Liabilities Q2 2025 · Dec 31, 2024 $2.37M
Total Liabilities Q2 2025 · Jun 30, 2025 $7.3M
Total Liabilities Q2 2025 · Dec 31, 2024 $6.22M
Current Assets Q2 2025 · Jun 30, 2025 $7.99M
Current Assets Q2 2025 · Dec 31, 2024 $5.68M
Total Assets Q2 2025 · Jun 30, 2025 $8.94M
Total Assets Q2 2025 · Dec 31, 2024 $6.72M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.66
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.15
Eps Diluted Q2 2025 · Jun 30, 2024 $0.51
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.74
Eps Basic Q2 2025 · Jun 30, 2025 −$0.66
Eps Basic Q2 2025 · Jun 30, 2025 −$1.15
Eps Basic Q2 2025 · Jun 30, 2024 $0.61
Eps Basic Q2 2025 · Jun 30, 2024 −$1.74
Sga Expense Q2 2025 · Jun 30, 2025 $2.54M
Sga Expense Q2 2025 · Jun 30, 2025 $5.45M
Sga Expense Q2 2025 · Jun 30, 2024 $2.32M
Sga Expense Q2 2025 · Jun 30, 2024 $3.54M
Rd Expense Q2 2025 · Jun 30, 2025 $3.15M
Rd Expense Q2 2025 · Jun 30, 2025 $6.1M
Rd Expense Q2 2025 · Jun 30, 2024 $1.59M
Rd Expense Q2 2025 · Jun 30, 2024 $2.7M
Net Income Q2 2025 · Jun 30, 2025 −$6.45M
Net Income Q2 2025 · Jun 30, 2025 −$11.26M
Net Income Q2 2025 · Jun 30, 2024 $5.2M
Net Income Q2 2025 · Jun 30, 2024 −$9.81M
Operating Income Q2 2025 · Jun 30, 2025 −$5.57M
Operating Income Q2 2025 · Jun 30, 2025 −$11.42M
Operating Income Q2 2025 · Jun 30, 2024 −$3.87M
Operating Income Q2 2025 · Jun 30, 2024 −$6.19M
Revenue Q2 2025 · Jun 30, 2025 $130K
Revenue Q2 2025 · Jun 30, 2025 $130K
Revenue Q2 2025 · Jun 30, 2024 $51K
Revenue Q2 2025 · Jun 30, 2024 $56K